In the colorectal cancer TCGA cohort, 99.1% of TP53 mutations, 98.7% of KRAS mutations, and 89.7% of APC mutations are deemed oncogenic or likely oncogenic by the OncoKB database. Here, TP53 is linked to colorectal cancer.